All these works have raised the hypothesis that alteration of the HMGA2 protein could confer a proliferative advantage to altered progenitors, triggering the pathogenesis of MPN or other clonal hematological diseases [127], but how HMGA2 intervenes directly in the pathogenesis of MPN remains to be clarified. The gene discussed is HMGA2; the disease is myeloproliferative disorder.